Synonyms: ARQ-751 | GLXC-26917
Compound class:
Synthetic organic
Comment: Vevorisertib (GLXC-26917, and formerly ARQ-751) is an allosteric, pan-AKT inhibitor that was designed for anti-tumour potential. The vevorisertib programme was terminated (for business reasons).
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-[1-[3-[3-[4-(1-aminocyclobutyl)phenyl]-2-(2-aminopyridin-3-yl)imidazo[4,5-b]pyridin-5-yl]phenyl]piperidin-4-yl]-N-methylacetamide |
International Nonproprietary Names | |
INN number | INN |
11383 | vevorisertib |
Synonyms |
ARQ-751 | GLXC-26917 |
Database Links | |
CAS Registry No. | 1416775-46-6 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4802156 |
GtoPdb PubChem SID | 479821403 |
PubChem CID | 71138858 |
Search Google for chemical match using the InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | NZDSLYATTDIDPH |
Search PubMed clinical trials | vevorisertib |
Search PubMed titles | vevorisertib |
Search PubMed titles/abstracts | vevorisertib |
UniChem Compound Search for chemical match using the InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |